Fate Therapeutics, Inc. (FATE)

NASDAQ: FATE · IEX Real-Time Price · USD

4.270

-0.040 (-0.93%)

At close: Jul 19, 2024, 4:00 PM

4.500

+0.230 (5.39%)

Pre-market: Jul 22, 2024, 7:00 AM EDT

Fate Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2011
Revenue	6.48	63.53	96.3	55.85	31.43	10.68	Upgrade
Revenue Growth (YoY)	-95.27%	-34.03%	72.44%	77.66%	194.33%	125.32%	Upgrade
Gross Profit	6.48	63.53	96.3	55.85	31.43	10.68	Upgrade
Selling, General & Admin	80.36	81.45	84.23	57.32	33.9	23.64	Upgrade
Research & Development	139.11	172.6	320.45	215.52	125.62	87.77	Upgrade
Operating Expenses	219.47	254.04	404.69	272.84	159.52	111.41	Upgrade
Operating Income	-212.99	-190.51	-308.39	-216.99	-128.09	-100.73	Upgrade
Interest Expense / Income	0	0	0	0	0	1.75	Upgrade
Other Expense / Income	-22.94	-29.58	-26.67	-4.84	45.3	-4.33	Upgrade
Pretax Income	-190.05	-160.93	-281.72	-212.15	-173.39	-98.15	Upgrade
Net Income	-190.05	-160.93	-281.72	-212.15	-173.39	-98.15	Upgrade
Shares Outstanding (Basic)	101	98	97	95	82	68	Upgrade
Shares Outstanding (Diluted)	101	98	97	95	82	68	Upgrade
Shares Change	3.11%	1.64%	2.19%	15.01%	20.82%	21.35%	Upgrade
EPS (Basic)	-1.92	-1.64	-2.91	-2.24	-2.10	-1.44	Upgrade
EPS (Diluted)	-1.92	-1.64	-2.91	-2.24	-2.10	-1.44	Upgrade
Free Cash Flow	-139.78	-138.42	-283.77	-213.57	-44.16	-90.57	Upgrade
Free Cash Flow Per Share	-1.38	-1.41	-2.93	-2.25	-0.54	-1.33	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-3287.85%	-299.86%	-320.23%	-388.56%	-407.47%	-943.14%	Upgrade
Profit Margin	-2933.79%	-253.30%	-292.55%	-379.89%	-551.59%	-919.00%	Upgrade
Free Cash Flow Margin	-2157.83%	-217.86%	-294.68%	-382.43%	-140.49%	-848.03%	Upgrade
EBITDA	-171.14	-142.65	-267.96	-206.3	-170.3	-94.2	Upgrade
EBITDA Margin	-2641.85%	-224.52%	-278.26%	-369.41%	-541.77%	-882.06%	Upgrade
Depreciation & Amortization	18.91	18.28	13.76	5.85	3.09	2.19	Upgrade
EBIT	-190.05	-160.93	-281.72	-212.15	-173.39	-96.4	Upgrade
EBIT Margin	-2933.79%	-253.30%	-292.55%	-379.89%	-551.59%	-902.59%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).